Guidelines for Fragile X (FMR1) Testing in Women with Primary Ovarian Insufficiency

Testing Strategy and Reflex Component

Reflex testing that automatically proceeds to Southern blot analysis after an initial PCR screen ensures detection of both FMR1 premutations and mosaic full‑mutation subpopulations in women with primary ovarian insufficiency (POI) 1, 2, 3.
Traditional PCR alone can miss full mutations in mosaic samples because it preferentially amplifies the smaller premutation allele, leaving the full‑mutation subpopulation undetected 1, 3, 4.
Phenotypic risk assessment differs markedly between an isolated premutation and size‑mosaicism (co‑existing premutation and full‑mutation alleles), influencing the likelihood of FXPOI, FXTAS, and offspring outcomes 1, 3, 4.
The American College of Medical Genetics and Genomics (ACMG) explicitly recommends that Southern blot analysis be performed alongside PCR for all samples, even when a premutation is identified, to avoid occult full‑mutation cases 1, 2, 3.

Triplet‑repeat‑primed PCR (TRP‑PCR) with capillary electrophoresis provides high analytical sensitivity and can detect mosaicism down to approximately 10 % of the cell population 5, 1.
Methylation‑specific PCR methods can determine allele size (up to ≈250 CGG repeats) and methylation status without requiring Southern blot 5, 1.
These advanced PCR‑based approaches eliminate the need for reflexive Southern blot on every specimen because they overcome the limitations of traditional PCR 5, 1.

Premutation alleles (55–200 CGG repeats) are unstable and may expand to full mutations during maternal transmission 7, 8.
The smallest premutation documented to expand to a full mutation within one generation contains 56 CGG repeats 7, 8.
Size mosaicism—co‑existence of methylated full‑mutation alleles with unmethylated premutation alleles—affects clinical phenotype and counseling recommendations 7, 1, 4.
Intermediate/gray‑zone alleles (45–54 CGG repeats) should be reported, although current large‑scale studies have not confirmed an association with POI 7.

PCR alone should never be used without reflex capability unless the laboratory employs TRP‑PCR or methylation‑sensitive methods that can reliably detect full‑mutation alleles 1, 2, 3.
In female patients, the separation of two normal alleles of different sizes can mimic a normal + premutation pattern (e.g., 20 & 44 repeats vs. 35 & 59 repeats); therefore, assays with superior resolution are required 9, 1, 4.
Skewed X‑inactivation in females can obscure premutation detection on Southern blot when methylation‑sensitive enzymes are used, necessitating careful result interpretation 9.

All pregnancies should be offered prenatal diagnostic testing (chorionic villus sampling or amniocentesis) to assess for possible expansion to a full mutation 8, 2.
First‑degree relatives of the proband (both male and female) should be offered targeted testing because male carriers are at risk for FXTAS and female carriers face reproductive and health risks 8, 1.